Somanetics Corp (NASDAQ:SMTS)

CAPS Rating: 4 out of 5

Develops, manufactures and markets the INVOS Cerebral Oximeter, the only non-invasive patient monitoring system commercially available in the United States that continuously measures changes in the blood oxygen level in the adult brain.

Recs

1
Player Avatar SuspectCRo (< 20) Submitted: 6/28/2007 10:52:02 AM : Outperform Start Price: $18.57 SMTS Score: +42.15

strong margins and growth, good liquidity and a niche market in healthcare, should be stong for two years until the next best thing comes out.

Report this Post 1 Comment
Member Avatar blearynet (< 20) Submitted: 7/13/2007 1:31:27 AM
Recs: 0

Did you mean "strong" for two years? I hope so...I'm long SMTS but it hasn't gone anywhere. I am beginning to wonder whether this has been a wise purchase.

Featured Broker Partners


Advertisement